Background Inhaled anticholinergics given in addition to β 2‐agonists are effective in
reducing hospital admissions in children presenting to the emergency department with a …

Background: Current guidelines recommend the use of a combination of inhaled β2 agonists
and anticholinergics, particularly for patients with acute severe or life threatening asthma in …

Background Inhaled anticholinergics as single agent bronchodilators (or in combination with
beta 2‐agonists) are one of the several medications available for the treatment of acute …

Background Anti-cholinergic agents and beta2-agonist drugs are both bronchodilators used
to reverse acute bronchospasm in children with asthma. These drugs have different modes …

Background There are several treatment options for managing acute asthma exacerbations
(sustained worsening of symptoms that do not subside with regular treatment and require a …

Objectives To estimate the therapeutic and adverse effects of addition of inhaled
anticholinergics to β 2 agonists in acute asthma in children and adolescents. Design …

The role for anticholinergic medications in acute asthma is not well-defined. Thus, the use of
therapy with anticholinergics and β 2-agonists, either simultaneously or in sequence, has …

Background Inhaled beta‐agonist therapy is central to the management of acute asthma.
This review evaluates the benefit of an additional use of intravenous beta2‐agonist agents …

Background Inhaled short‐acting anticholinergics (SAAC) and short‐acting beta₂‐agonists
(SABA) are effective therapies for adult patients with acute asthma who present to the …

Background Since the advent of inhaled ß 2‐agonists, anticholinergic agents and
glucocorticoids, the role of aminophylline in paediatric acute asthma has become less clear …